I think travel demand will soften next year as higher interest rates bite, but domestic travel in particular has a lot of momentum and a positive medium-term outlook, judging by Federal Government forecasts for travel demand to 2027. Here are two travel stocks to consider, given their current prices.
I think the timing is right for a cautious look at emerging-market equities. Here are three ways to gain exposure to emerging-market equities and bonds through Exchange Traded Funds (ETFs) on the ASX. I’ve outlined an index strategy (IEM), a smart-beta strategy (VanEck) and an active strategy (Fidelity).
Here are two ways to gain exposure to growth in international students studying in Australia and demand for English-language testing services:
Here are two stocks to consider. Both are well down from their 52-week high as the market frets about a slowing economy.
Here are two stocks to consider. Both are well down from their 52-week high as the market frets about a slowing economy.
Fineos Corp Holdings and Hansen Technologies are well placed as legacy technology systems are replaced.
Here are two listed investment companies trading at large discounts.
I normally favour investing in gold through ETFs that provide gold-bullion exposure and are currency hedged. This strategy eliminates equity-market, company and currency risk, and provides pure gold exposure. Here are two opportunities in ETFs that hold a diversified basket of global gold producers.
Healthcare stocks ResMed and SomnoMed offer value after heavy falls.
Here are two disappointing stocks I’ve favoured in the past few years, and an explanation of what’s gone wrong and if value still exists. My tip: learn to know when you’ve got it wrong so you can cut your losses and move on.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.